Latest Market News

Thorney Technologies reported a sharply reduced half-year profit amid challenging market conditions but extended its share buyback to support shareholder value.

Orcoda Limited has reported strong half-year FY26 results, showcasing significant growth in revenue, EBITDA, and recurring revenue as it advances its AI-powered transport ecosystem solutions.

SolGold shareholders have approved the recommended cash acquisition by Jiangxi Copper, a move that directly impacts DGR Global’s substantial investment in the company. Completion awaits court approval and further conditions.

CVC Limited posted a $6.7 million net loss for the half-year ended December 2025, driven by project delays and absent property sales, while strengthening liquidity through refinancing.

K&S Corporation’s half-year results reveal a notable decline in revenue and net profit, accompanied by a reduced interim dividend, signaling challenges ahead for the logistics firm.

Papyrus Australia Limited reported a reduced half-year loss and marked a significant commercial milestone with a $4.2 million supply contract, advancing its transition from technology development to early-stage commercialisation.

SIV Capital Limited reported a 29.7% increase in its half-year loss to $172,763, with revenue down 41%, while its ASX suspension continues as it pursues a confidential transaction to regain listing status.

Aspermont Limited has announced a significant security consolidation, reducing its ordinary shares on issue from nearly 2.91 billion to just over 11.6 million, aiming to streamline its capital structure and potentially enhance market liquidity.

TrivarX Limited reported a $1.26 million half-year loss as it completed the acquisition of Stabl-Im brain imaging IP and validated its mental health screening technology in veterans. The company raised $4.2 million to fund clinical development and expand its diagnostic portfolio.

333D Limited reported a 23% increase in revenue to $588,678 for the half-year ended December 2025, despite a 92% plunge in profit after tax to a $282,030 loss. The company boosted its cash reserves significantly and initiated a strategic Bitcoin investment.

QEM Limited confirms a $1.442 million capital raising via placement, addressing ASX queries on disclosure timing and compliance. The company clarifies board approvals and trading halt details, reinforcing its adherence to continuous disclosure obligations.

Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.